Where can I find the specific financial results for Gilead Sciences for the period ending December 31, 2016?

The specific financial results for the fourth quarter and full year ended December 31, 2016, are detailed in the press release issued by Gilead on February 7, 2017, which is attached as Exhibit 99.1 to this 8-K filing.

What is the difference between GAAP and non-GAAP financial information, and why does Gilead present both?

GAAP (Generally Accepted Accounting Principles) are the standard accounting rules in the U.S. Non-GAAP measures are financial metrics that exclude certain items that management believes are not indicative of ongoing operational performance. Gilead presents non-GAAP information because management finds it useful for internal operational, budgeting, and financial planning, and believes it can also be useful for investors to supplement their understanding of the company's results. However, investors should refer to the reconciliation provided in the press release for a clear understanding of how non-GAAP figures are derived from GAAP.

Does this 8-K filing change Gilead's reporting obligations or liabilities?

The filing explicitly states that the information in this Form 8-K and its exhibits shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference into any other filing. This means the company is providing notice of the information but not assuming the same level of liability as a standard filing under Section 18.

GILD 8-K: Earnings & Results

Summary

Gilead Sciences, Inc. (GILD) filed an 8-K report on February 7, 2017, announcing its financial results for the fourth quarter and full year ended December 31, 2016. The report primarily consists of a press release detailing these results, which were presented on both a GAAP and non-GAAP basis. Management highlights the usefulness of non-GAAP measures for internal operational and financial planning, encouraging investors to consider these alongside the official GAAP statements for a comprehensive understanding of performance. Investors should note that the specific financial figures and performance metrics for Q4 and FY 2016 are contained within the press release (Exhibit 99.1) attached to this 8-K. The company emphasizes that non-GAAP information may be defined and calculated differently by other companies, and a reconciliation between GAAP and non-GAAP figures is provided in the press release. This filing serves as the official notification of these results, though it clarifies that the information presented will not be deemed "filed" for purposes of certain sections of the Securities Exchange Act.

Key Highlights

1Gilead Sciences announced fourth quarter and full year 2016 financial results on February 7, 2017.
2The results were presented using both Generally Accepted Accounting Principles (GAAP) and non-GAAP financial measures.
3Management believes non-GAAP information provides valuable insights for investors, complementing GAAP results.
4Non-GAAP measures are used internally by Gilead for operating, budgeting, and financial planning.
5A reconciliation between GAAP and non-GAAP financial information is available in the press release (Exhibit 99.1).
6The press release detailing the financial results is filed as Exhibit 99.1 to this 8-K.
7The information furnished in this report is not considered 'filed' for certain purposes under the Securities Exchange Act of 1934.

GILEAD SCIENCES, INC. 8-K Report, Financial Results (Feb 7, 2017)

Summary

Key Highlights

Frequently Asked Questions